Precision Repair for High-Risk Patients: The NovoClasp Transcatheter Mitral Valve Clip System from Enlight Medical Is Approved by NMPA
The NovoClasp Transcatheter Mitral Valve Clip System is a breakthrough device that offers a life-changing, minimally invasive alternative for patients suffering from severe degenerative mitral...
ConBrella® Biodegradable PFO Occluder Approved by NMPA
ConBrella® Biodegradable Patent Foramen Ovale (PFO) Occluder System manufactured by Wuyou Tiaodong (WYTD) Medical Technology (Shenzhen) Co., Ltd. is officially approved by NMPA to launch...
Filling the Gap for High-Risk Patients: PIONEER TAVR® Transcatheter Aortic Valve System Approved by NMPA
Product Overview This innovative system from KOKA Lifesciences focuses on the precise clinical needs of elderly, high-risk patients suffering from symptomatic, severe aortic valve insufficiency...
Breakthrough in Precision Cardiac Access: RF-cross® Radiofrequency Transseptal Needle
Product Overview The RF-cross® is China’s first transseptal puncture system to integrate “Zero-Exchange” workflow, mechanical + radiofrequency (RF) dual technology, and steerable sheath compatibility. It...
Approval of the EasyEcho™ Intracardiac Echocardiography Imaging Catheter
On January 29, the National Medical Products Administration (NMPA) granted marketing approval to Shanghai MicroPort EP MedTech Co., Ltd. for the EasyEcho™ disposable intracardiac echocardiography...
China’s First: Meio Cardinav Medical’s Innovative Cardiac Electrophysiology Interventional Surgery Control System “TITIAN” Approved for Market Launch
November 14, 2025 On October 31st, the Cardiac Electrophysiology Interventional Surgery Control System, branded as “TITIAN” developed by Meio Cardinav Medical, received market approval from...
Zhongke Yian Medical Technology Launches High-nitrogen Nickel-free Stainless Steel Coronary Stent System
Zhongke Yian Medical Technology (Beijing) Co., Ltd. announced today the official market approval and launch of its innovative Sirolimus Drug-Eluting Coronary Stent System. Approved on...
World’s First Nanosecond PFA System Received NMPA Approval
On June 27, China’s National Medical Products Administration (NMPA) officially approved the market launch of the NxPFA® cardiac nanosecond pulsed field ablation system, developed by...
The World’s First Pre-loaded, Dry-packaged TAVR System Approved by NMPA
On April 9, 2025, KingstronBio received approval from China’s National Medical Products Administration (NMPA) for its ProStyle A® Transcatheter Aortic Valve Replacement (TAVR) System. This...
Shanghai Shineyo Medical’s Cardiac PFA System Gains NMPA Approval, Expanding Atrial Fibrillation Treatment Options in China
On February 26, 2025, the SHINERHYTHM™ cardiac pulsed field ablation system and RHYTHPULSE™ single-use cardiac pulsed field ablation catheter developed by Shanghai Shineyo Medical Instrument...